INVESTUDY.ORG
  • Home
  • ECONOMY
  • STOCK INVESTMENT
  • COMPANY ANALYSIS
  • CRYPTOCURRENCY
  • TAXES/LAWS
  • EDUCATION
  • REAL ESTATE
No Result
View All Result
SUBSCRIBE
INVESTUDY.ORG
  • Home
  • ECONOMY
  • STOCK INVESTMENT
  • COMPANY ANALYSIS
  • CRYPTOCURRENCY
  • TAXES/LAWS
  • EDUCATION
  • REAL ESTATE
No Result
View All Result
Investudy.org
No Result
View All Result
Home COMPANY ANALYSIS

High-Yield Dividend Stocks to Buy During a Market Sell-Off

2025-04-25
in COMPANY ANALYSIS, STOCK INVESTMENT
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

You might also like

Essential Economic Indicators You Must Watch to Understand Global Markets

How to Identify Market Tops and Bottoms in the Stock Market

Read the 10-K and 10-Q Reports! A Guide to Essential SEC Filings for Investors

Johnson & Johnson (NYSE: JNJ)

Johnson & Johnson is a well-known brand in the pharmaceutical and consumer healthcare markets. With a diverse business model spanning pharmaceuticals, medical technology, and consumer products, the company holds a significant market presence. However, by the end of this year, J&J plans to spin off its consumer health division into a new company called Kenvue.

The primary goal of this spin-off is to focus more on its highest revenue-generating segment—pharmaceuticals. This division includes several high-performing immunology and oncology drugs.

  • Stelara and Tremfya, two immunology treatments, grew double digits last year, generating a combined revenue of $12.3 billion.
  • Darzalex, an oncology treatment for multiple myeloma, saw its sales surge 32% to $8 billion in 2022.
  • Erleada, a prostate cancer treatment, grew 45.7% to $1.9 billion.
  • The pharmaceutical segment as a whole generated $52.5 billion in revenue in 2022.

J&J continues to invest heavily in future growth, spending $14.6 billion on R&D last year. Many of the pipeline drugs could become major revenue drivers in the coming years.

J&J’s stable and growing business has led to 60 consecutive years of annual dividend increases, earning it the title of “Dividend King.”

  • Dividend payout ratio: 41%
  • Dividend yield: 2.8% (much higher than the S&P 500’s average yield of 1.7%)

With strong and consistent cash flow, the company can easily sustain its dividend payments.

J&J has a proven track record of performing well even in downturns, making it a strong long-term investment for consistent dividend payments during volatile periods.


Medtronic (NYSE: MDT)

Medtronic has built a strong reputation as a dividend stock, having increased its dividend for 45 consecutive years. This steady growth in payouts highlights the company’s ability to maintain business stability over time.

  • Current dividend yield: 3.24% (significantly higher than the market average)

While Medtronic’s recent earnings may have raised concerns among investors, the company remains fundamentally strong.

  • In Q3 of the 2023 fiscal year (ending January 27), Medtronic reported flat total revenue of $7.7 billion compared to the prior year.
  • Adjusted EPS declined 4% year-over-year to $1.30.
  • Management attributed the drop to external macroeconomic headwinds.

However, Medtronic expects stable revenue growth in future quarters as these short-term challenges subside.

Despite the temporary slowdown, Medtronic ended the quarter with $2.5 billion in free cash flow, which should comfortably support its dividend payments and long-term growth strategies.

While growth stocks are often susceptible to short-term headwinds, the key factor is long-term potential.

Medtronic has substantial room to expand within the medical device industry, which is projected to grow at a CAGR of 5.5%, reaching $719 billion by 2029.

The company is also entering the rapidly expanding robotic surgery market.

  • Hugo RAS, Medtronic’s robotic-assisted surgical system, has already been approved in international markets.
  • Management reports strong sales momentum.
  • In December, Hugo RAS was used for the first-ever robot-assisted urological procedure in the U.S.

With its diverse product portfolio and consistent dividend payouts, Medtronic remains an attractive healthcare stock for long-term investors.

Recommended For You

Essential Economic Indicators You Must Watch to Understand Global Markets

by investudy
2025-05-07
0

Across the world, both public institutions and private companies release a wide range of economic indicators that reflect the economic health of different countries. Fortunately, websites like TradingEconomics...

Read moreDetails

How to Identify Market Tops and Bottoms in the Stock Market

by investudy
2025-05-07
0
How to Identify Market Tops and Bottoms in the Stock Market

Many online trading platforms provided by securities firms offer a wide range of useful tools, charts, and indicators. Among them, the one I use most frequently is Webull,...

Read moreDetails

Read the 10-K and 10-Q Reports! A Guide to Essential SEC Filings for Investors

by investudy
2025-04-30
0
Read the 10-K and 10-Q Reports! A Guide to Essential SEC Filings for Investors

The 10-K and 10-Q reports are official documents that publicly traded companies are required to file with the U.S. Securities and Exchange Commission (SEC) under U.S. securities laws....

Read moreDetails

How to Calculate Fair Value of a Stock (Intrinsic Value Explained)

by investudy
2025-04-30
0

Fair value is considered the most reasonable price for a stock. It reflects the price or price range at which an asset or liability could be bought or...

Read moreDetails

Palantir: The Ultimate Defense & Tariff-Resilient AI Stock

by investudy
2025-04-21
0
Palantir: The Ultimate Defense & Tariff-Resilient AI Stock

Outperforming Market Momentum Although Palantir experienced a larger drop from its peak compared to the S&P 500 (46% vs 21%), its rebound has been significantly stronger (around 40%...

Read moreDetails
Next Post
Everything About NASDAQ

Two Unstoppable Growth Stocks to Buy Right Now

Please login to join discussion

Related News

P/E ratio, Trailing P/E, Forward P/E

P/E ratio, Trailing P/E, Forward P/E

2025-04-25

US Stock Wash Sale Rule (WASH SALE RULE)

2025-04-25
Dollar Index (USDX) – Economics

Dollar Index (USDX) – Economics

2025-04-25

Browse by Category

  • BONDS
  • BUSINESS
  • COMPANY ANALYSIS
  • CRYPTOCURRENCY
  • ECONOMY
  • EDUCATION
  • REAL ESTATE
  • STOCK INVESTMENT
  • TAXES/LAWS

INVESTUDY.ORG

Learn about the basics of successful investing, the right investment attitude, and how to gain valuable insights for many investors to embark on the path to successful investing.

CATEGORIES

  • BONDS
  • BUSINESS
  • COMPANY ANALYSIS
  • CRYPTOCURRENCY
  • ECONOMY
  • EDUCATION
  • REAL ESTATE
  • STOCK INVESTMENT
  • TAXES/LAWS

BROWSE BY TAG

ai AI Boom Big Tech Stocks Bitcoin BOJ Rate Hike BPS Buffett Cryptocurrencies Currency Trading dividend Economy emotional intelligence relationships equity research etf fair value calculation Fed Tapering fundamental analysis Global Markets how to build meaningful connections intrinsic value Investment Strategies Japanese Interest Rates loneliness vs solitude Market Fear Market Signals NVIDIA Obligation S&P 500 Stimulus Trigger stock investing tips stock market timing stock valuation Strategy technical analysis toxic relationships signs U.S. Stock Market Unemployment Rate US Crypto Regulation value investing Visa Warren Buffett investing when to cut off someone Yen Carry Trade Yen Carry Trade Unwinding 배당주

© 2023 Investudy.org - Stock, cryptocurrency, economic news, and real estate information sharing.

No Result
View All Result
  • Home
  • ECONOMY
  • STOCK INVESTMENT
  • COMPANY ANALYSIS
  • CRYPTOCURRENCY
  • TAXES/LAWS
  • EDUCATION
  • REAL ESTATE

© 2023 Investudy.org - Stock, cryptocurrency, economic news, and real estate information sharing.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?